No differences seen among one-, two-, and three-year interval cancer predictions, age quartiles, or breast densities
MONDAY, Nov. 3, 2025 (HealthDay News) — Risk scores generated by a deep learning algorithm (Mirai) can identify women at higher risk for developing interval breast cancers (ICs), according to a study published online Oct. 28 in Radiology.
Joshua W.D. Rothwell, from the University of Cambridge School of Clinical Medicine in the United Kingdom, and colleagues examined the predictive ability of three-year risk scores generated by Mirai to identify women who developed ICs in the U.K. breast screening program. Digital screening mammograms with negative results collected from a three-year cohort were processed by Mirai.
The analysis included 134,217 examinations from the same number of women and included 524 ICs. No evidence was seen for performance differences among one-, two-, and three-year IC predictions, age quartiles, or breast densities. For one-, two-, and three-year IC predictions, the areas under the receiver operating characteristic curves were 0.72, 0.67, and 0.67, respectively. For age quartiles, C-indexes were 0.67, 0.70, 0.71, and 0.71 for those younger than 52, 52 to 58, 59 to 65, and 66 years and older, respectively. For Breast Imaging Reporting and Data System categories a, b, c, and d, C indexes were 0.70, 0.69, 0.68, and 0.67, respectively. For women assigned the highest 1, 5, 10, and 20 percent of scores, three-year risk scores retrospectively predicted 3.6, 14.5, 26.1, and 42.4 percent of ICs, respectively.
“Further workup of mammograms within the top 20 percent of scores could yield 42.4 percent of interval cancers, meaning that Mirai could be used to identify women for supplemental imaging or a shortened screening interval, instead of or in addition to breast density,” Rothwell said in a statement.
Several authors disclosed ties to the biopharmaceutical and medical device industries.
Depression Risk Higher Among Long-Term Breast Cancer Survivors Than Women Without Breast Cancer History
Chest Wall Irradiation Does Not Improve Survival in Intermediate-Risk Breast Cancer
Abemaciclib + Endocrine Therapy Improves Survival in HR-Positive, HER2-Negative Early Breast Cancer
Incidence Rates Increased From 2003 to 2017 for Six Cancer Types in 42 Countries
Multicancer Early Detection Test Reduces Late-Stage Diagnoses
Most U.S. Adults Misunderstand Impact of Alcohol on Cancer Risk
Prevalence of Key Cancer Susceptibility Genes Higher Than Expected
Physical Activity Levels Linked to Risk for Digestive System Cancers